Stock profile
GSK plc
GSK.LSE
LSE
GBX
ISIN GB00BN7SWP63
Market tone: Positive sentiment score 1.00 from 1 mentions, latest 20 Mar 2026.
Open 1,963.50p
Prev close 1,962.50p
Volume 5,294,964
Frequency
Quarterly
3.6 events/year
Trend
Falling
2022-2026 payout trend
Volatility
20.25%
annual payout CV
Growth
-15.10%
annualised payout
Recent Dividends
Dividend16.0pQuarterly
Event yield1.03% - 1.27%declared to ex-div
Ex-div drop-1.39%price move
Decl11 Nov
Ex-div14 Aug
Pay09 Oct
Dividend16.0pQuarterly
Event yield0.88% - 1.27%declared to ex-div
Ex-div drop-0.71%price move
Decl11 Nov
Ex-div13 Nov
Pay08 Jan
Dividend18.0pQuarterly
Event yield0.79% - 1.42%declared to ex-div
Ex-div drop-1.85%price move
Decl11 Nov
Ex-div19 Feb
Pay09 Apr
Dividend17.0pQuarterly
Event yield0.75% - 0.97%declared to ex-div
Ex-div drop-0.72%price move
Decl10 Nov
Ex-div14 May
Pay09 Jul
Price History
25 Nov 2024 to 12 Jun 2026
1,183.68
1,474.84
1,766.00
2,057.16
2,348.32
Jan 25
Apr 25
Jul 25
Oct 25
Jan 26
Apr 26
Decl 11 Nov
Ex 14 Aug
Pay 09 Oct
Decl 11 Nov
Ex 13 Nov
Pay 08 Jan
Decl 11 Nov
Ex 19 Feb
Pay 09 Apr
Decl 10 Nov
Ex 14 May
Pay 09 Jul
16.0p Quarterly
- Declared
- 11 Nov
- Ex-div
- 14 Aug
- Yield
- 1.03%–1.27%
- Ex-drop
- -1.39%
- Paid
- 09 Oct
16.0p Quarterly
- Declared
- 11 Nov
- Ex-div
- 13 Nov
- Yield
- 0.88%–1.27%
- Ex-drop
- -0.71%
- Paid
- 08 Jan
18.0p Quarterly
- Declared
- 11 Nov
- Ex-div
- 19 Feb
- Yield
- 0.79%–1.42%
- Ex-drop
- -1.85%
- Paid
- 09 Apr
17.0p Quarterly
- Declared
- 10 Nov
- Ex-div
- 14 May
- Yield
- 0.75%–0.97%
- Ex-drop
- -0.72%
- Paid
- 09 Jul
News
EODHD feed
13 Jun 2026
Positive 0.98
GSK Engitix Liver Fibrosis Pact Adds Early Stage Upside For Valuation
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
GSK (LSE:GSK) and Engitix Ltd. have agr
11 Jun 2026
Positive 0.99
Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors
HALIFAX, NS, June 11, 2026 /CNW/ - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce the appointment of Michael A. Fleming to the boar
10 Jun 2026
Positive 0.95
GSK Buys Nuvalent To Deepen Oncology Focus And Future Lung Cancer Revenue
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
GSK (LSE:GSK) has agreed to acquire US biotech Nuvalent in a dea
09 Jun 2026
Positive 0.99
GSK Just Dropped $10.6 Billion on a Lung Cancer Bet
GSK Just Dropped $10.6 Billion on a Lung Cancer Bet - Moby
THE GIST
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'l
09 Jun 2026
Positive 0.84
GSK Buys Nuvalent for $10.6 Billion to Expand Cancer Line
(Bloomberg) -- GSK Plc agreed to buy Nuvalent Inc. in a deal valued at $10.6 billion (7.9 billion pounds), adding a biotech firm that's developing treatments for lung cancer as the
04 Jun 2026
Positive 1.00
GSK Hepatitis B Data Clarifies Bepirovirsen’s Role In Future Growth
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
GSK (LSE:GSK) and partner Chia Tai Tianqing reported positive pi
Historical Dividends
Total dividends and yield-at-ex-date by year
Payout trend
-5.66%
Falling · 2021-2025 payout CAGR
Payout volatility
12.81%
Stable · std dev / average payout
Peak payout80.8p
Peak annual yield7.11%
2021
18 Feb 23.2p
20 May 19.2p
19 Aug 19.2p
18 Nov 19.2p
2022
24 Feb 23.2p
19 May 14.1p
18 Aug 16.2p
17 Nov 13.8p
2023
23 Feb 13.8p
18 May 14.0p
17 Aug 14.0p
16 Nov 14.0p
2024
22 Feb 16.0p
16 May 15.0p
15 Aug 15.0p
14 Nov 15.0p
2025
20 Feb 16.0p
15 May 16.0p
14 Aug 16.0p
13 Nov 16.0p
2026
This year
19 Feb 18.0p
14 May 17.0p
14 Aug 16.0p
13 Nov 16.0p
2027
Projection
19 Feb 18.0p
14 May 17.3p
14 Aug 16.0p
13 Nov 16.0p
| Year | Ex-date | Declared | Record | Payment | Period | Value |
|---|---|---|---|---|---|---|
| 2026 | 14 May 2026 | 10 Nov 2025 | - | 09 Jul 2026 | Quarterly | 0.1700 GBP |
| 2026 | 19 Feb 2026 | 11 Nov 2024 | - | 09 Apr 2026 | Quarterly | 0.1800 GBP |
| 2025 | 13 Nov 2025 | 11 Nov 2024 | - | 08 Jan 2026 | Quarterly | 0.1600 GBP |
| 2025 | 14 Aug 2025 | 11 Nov 2024 | - | 09 Oct 2025 | Quarterly | 0.1600 GBP |
| 2025 | 15 May 2025 | 11 Nov 2024 | - | 10 Jul 2025 | Quarterly | 0.1600 GBP |
| 2025 | 20 Feb 2025 | 04 Dec 2023 | - | 10 Apr 2025 | Quarterly | 0.1600 GBP |
| 2024 | 14 Nov 2024 | 04 Dec 2023 | 14 Nov 2024 | 09 Jan 2025 | Quarterly | 0.1500 GBP |
| 2024 | 15 Aug 2024 | 04 Dec 2023 | 15 Aug 2024 | 10 Oct 2024 | Quarterly | 0.1500 GBP |
| 2024 | 16 May 2024 | 04 Dec 2023 | 16 May 2024 | 11 Jul 2024 | Quarterly | 0.1500 GBP |
| 2024 | 22 Feb 2024 | 24 Nov 2022 | 22 Feb 2024 | 11 Apr 2024 | Quarterly | 0.1600 GBP |
| 2023 | 16 Nov 2023 | 24 Nov 2022 | 16 Nov 2023 | 11 Jan 2024 | Quarterly | 0.1400 GBP |
| 2023 | 17 Aug 2023 | 24 Nov 2022 | 17 Aug 2023 | 12 Oct 2023 | Quarterly | 0.1400 GBP |
| 2023 | 18 May 2023 | 24 Nov 2022 | 18 May 2023 | 13 Jul 2023 | Quarterly | 0.1400 GBP |
| 2023 | 23 Feb 2023 | 24 Nov 2021 | 23 Feb 2023 | 13 Apr 2023 | Quarterly | 0.1375 GBP |
Upcoming Dividends
Declared and projected dividend cycle| Ex-date | Status | Period | Dividend | Est. yield |
|---|---|---|---|---|
| 14 May 2027 | Predicted | Quarterly | 0.1733 GBP | 0.87% |
Recovery Signature
Post ex-div behaviourMedian recovery2dtrading days to regain pre-ex close
Recovered83.33%events recovered inside 6w
Drop capture99.00%ex-drop as share of dividend paid
Score83speed, consistency, and drift blend
Bold white line = average visible recovery curve
6 events selected